TrialJAMA2021

Effect of Capecitabine Maintenance Therapy Using Lower Dosage and Higher Frequency vs Observation on Disease-Free Survival Among Patients With Early-Stage Triple-Negative Breast Cancer Who Had Received Standard Treatment: The SYSUCC-001 Randomized Clinical Trial.

Xi Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.